{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35701649", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "08", "Day": "15"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "14"}], "Language": ["eng"], "ELocationID": ["9910", "10.1038/s41598-022-14174-1"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "12", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "14"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "Anticancer effects of herbal medicines in pancreatic ductal adenocarcinoma through modulation of steroid hormone response proteins.", "Pagination": {"StartPage": "9910", "MedlinePgn": "9910"}, "Abstract": {"AbstractText": ["Many individual herbs and herbal formulae have been demonstrated to provide safe and effective treatment for pancreatic ductal adenocarcinoma (PDAC); however, the therapeutic mechanisms underlying their effects have not been fully elucidated. A total of 114 herbal formulae comprising 216 single herbal medicines used to treat PDAC were identified. Cluster analysis revealed a core prescription including four herbs [Glycyrrhizae Radix et Rhizome (Gan Cao), Codonopsis Radix (Dang Shen), Citri Reticulatae Pericarpium (Chen Pi), and Pinelliae Rhizoma (Ban Xia)] in combination to treat PDAC, and 295, 256, 141, and 365 potential targets were screened for each of these four herbs, respectively. PDAC-related proteins (n\u2009=\u20092940) were identified from the DisGeNET database. Finally, 44 overlapping targets of herbs and PDAC were obtained, representing potential targets of the herbal medicines for PDAC treatment. GO enrichment analysis indicated that targets common to herbs and PDAC primarily functioned in response to steroid hormones. KEGG pathway enrichment analysis indicated that the herbs may prevent PDAC by influencing apoptotic, p53, and PI3K/Akt signaling pathways. Further, molecular docking analysis indicated that of identified bioactive compounds, stigmasterol, phaseol, perlolyrine, shinpterocarpin, and licopyranocoumarin have good binding ability with proteins involved in responses to steroid hormones, while stigmasterol, phaseol, perlolyrine, and DIOP have good binding ability with PTGS2(also known as COX-2), ESR1, ESR2, AR, and PGR. The anti-PDAC activity of herbal medicines may be mediated via regulation of proteins with roles in responses to steroid hormones. This study provides further evidence supporting the potential for use of herbal medicines to treat PDAC."], "CopyrightInformation": "\u00a9 2022. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Zhiyi", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Wang", "ForeName": "Juan", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Liu", "ForeName": "Bingying", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Coastal Salinity Tolerant Grass Engineering and Technology Research Center, Ludong University, Yantai, People's Republic of China."}], "LastName": "Liu", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Shi", "ForeName": "Xiaowei", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Li", "ForeName": "Wenli", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China."}], "LastName": "Xin", "ForeName": "Huawei", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China. xinjiezhongyao@126.com."}], "LastName": "Xin", "ForeName": "Jie", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy, Linyi University, Landshan District, Linyi City, 276000, Shandong Province, People's Republic of China. Chunxianghao@outlook.com."}], "LastName": "Hao", "ForeName": "Chunxiang", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Steroids"}, {"RegistryNumber": "99WUK5D0Y8", "NameOfSubstance": "Stigmasterol"}], "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Adenocarcinoma"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Hormones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Phosphatidylinositol 3-Kinases"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Steroids"}, {"QualifierName": [], "DescriptorName": "Stigmasterol"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Mohammed A, Janakiram NB, Pant S, Rao CV. Molecular targeted intervention for pancreatic cancer. Cancers (Basel) 2015;7:1499\u20131542. doi: 10.3390/cancers7030850.", "ArticleIdList": ["10.3390/cancers7030850", "PMC4586783", "26266422"]}, {"Citation": "Gansauge F, et al. NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial. Langenbecks Arch. Surg. 2002;386:570\u2013574. doi: 10.1007/s00423-001-0267-5.", "ArticleIdList": ["10.1007/s00423-001-0267-5", "11914932"]}, {"Citation": "Zemskov V, et al. Efficacy of ukrain in the treatment of pancreatic cancer. Langenbecks Arch. Surg. 2002;387:84\u201389. doi: 10.1007/s00423-002-0293-y.", "ArticleIdList": ["10.1007/s00423-002-0293-y", "12111260"]}, {"Citation": "Zemskov VS, et al. Ukrain (NSC-631570) in the treatment of pancreas cancer. Drugs Exp. Clin. Res. 2000;26:179\u2013190.", "ArticleIdList": ["11345025"]}, {"Citation": "Gasic U, et al. Polyphenols as possible agents for pancreatic diseases. Antioxidants (Basel) 2020;9:547. doi: 10.3390/antiox9060547.", "ArticleIdList": ["10.3390/antiox9060547", "PMC7346180", "32585831"]}, {"Citation": "Estrela JM, et al. Polyphenolic phytochemicals in cancer prevention and therapy: Bioavailability versus bioefficacy. J. Med. Chem. 2017;60:9413\u20139436. doi: 10.1021/acs.jmedchem.6b01026.", "ArticleIdList": ["10.1021/acs.jmedchem.6b01026", "28654265"]}, {"Citation": "Ratajczak K, Glatzel-Plucinska N, Ratajczak-Wielgomas K, Nowinska K, Borska S. Effect of resveratrol treatment on human pancreatic cancer cells through alterations of Bcl-2 family members. Molecules. 2021;26:6560. doi: 10.3390/molecules26216560.", "ArticleIdList": ["10.3390/molecules26216560", "PMC8588171", "34770968"]}, {"Citation": "Gutheil WG, Reed G, Ray A, Anant S, Dhar A. Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr. Pharm. Biotechnol. 2012;13:173\u2013179. doi: 10.2174/138920112798868566.", "ArticleIdList": ["10.2174/138920112798868566", "PMC4461363", "21466430"]}, {"Citation": "Marasini B, Sahu RP. Natural anti-cancer agents: Implications in gemcitabine-resistant pancreatic cancer treatment. Mini Rev. Med. Chem. 2017;17:920\u2013927. doi: 10.2174/1389557517666170315124438.", "ArticleIdList": ["10.2174/1389557517666170315124438", "28302042"]}, {"Citation": "Triantafillidis JK, Triantafyllidi E, Sideris M, Pittaras T, Papalois AE. Herbals and plants in the treatment of pancreatic cancer: A systematic review of experimental and clinical studies. Nutrients. 2022;14:619. doi: 10.3390/nu14030619.", "ArticleIdList": ["10.3390/nu14030619", "PMC8839014", "35276978"]}, {"Citation": "Yue Q, Gao G, Zou G, Yu H, Zheng X. Natural Products as adjunctive treatment for pancreatic cancer: Recent trends and advancements. Biomed. Res. Int. 2017;2017:8412508. doi: 10.1155/2017/8412508.", "ArticleIdList": ["10.1155/2017/8412508", "PMC5292383", "28232946"]}, {"Citation": "Kuo YT, et al. Use of complementary traditional Chinese medicines by adult cancer patients in Taiwan: A nationwide population-based study. Integr. Cancer Ther. 2018;17:531\u2013541. doi: 10.1177/1534735417716302.", "ArticleIdList": ["10.1177/1534735417716302", "PMC6041896", "28665160"]}, {"Citation": "Kuo YT, et al. Complementary Chinese herbal medicine therapy improves survival of patients with pancreatic cancer in Taiwan: A nationwide population-based cohort study. Integr. Cancer Ther. 2018;17:411\u2013422. doi: 10.1177/1534735417722224.", "ArticleIdList": ["10.1177/1534735417722224", "PMC6041895", "28774207"]}, {"Citation": "Yang X, et al. Survival benefits of western and traditional Chinese medicine treatment for patients with pancreatic cancer. Medicine (Baltimore) 2015;94:e1008. doi: 10.1097/MD.0000000000001008.", "ArticleIdList": ["10.1097/MD.0000000000001008", "PMC4504629", "26131801"]}, {"Citation": "Wong W, et al. Chinese herbal medicine effectively prolongs the overall survival of pancreatic cancer patients: A case series. Integr. Cancer Ther. 2019;18:1534735419828836. doi: 10.1177/1534735419828836.", "ArticleIdList": ["10.1177/1534735419828836", "PMC6432679", "30791742"]}, {"Citation": "Ashburner M, et al. Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25\u201329. doi: 10.1038/75556.", "ArticleIdList": ["10.1038/75556", "PMC3037419", "10802651"]}, {"Citation": "Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27\u201330. doi: 10.1093/nar/28.1.27.", "ArticleIdList": ["10.1093/nar/28.1.27", "PMC102409", "10592173"]}, {"Citation": "Tang Z, Kang B, Li C, Chen T, Zhang Z. GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u2013W560. doi: 10.1093/nar/gkz430.", "ArticleIdList": ["10.1093/nar/gkz430", "PMC6602440", "31114875"]}, {"Citation": "Kaptchuk, T. J. in McGraw-Hill Education (2000)."}, {"Citation": "Ding W, et al. Traditional Chinese herbs as chemical resource library for drug discovery of anti-infective and anti-inflammatory. J. Ethnopharmacol. 2014;155:589\u2013598. doi: 10.1016/j.jep.2014.05.066.", "ArticleIdList": ["10.1016/j.jep.2014.05.066", "24928828"]}, {"Citation": "Li L, Leung PS. Use of herbal medicines and natural products: An alternative approach to overcoming the apoptotic resistance of pancreatic cancer. Int. J. Biochem. Cell Biol. 2014;53:224\u2013236. doi: 10.1016/j.biocel.2014.05.021.", "ArticleIdList": ["10.1016/j.biocel.2014.05.021", "24875648"]}, {"Citation": "Park J, Jeong D, Song M, Kim B. Recent advances in anti-metastatic approaches of herbal medicines in 5 major cancers: From traditional medicine to modern drug discovery. Antioxidants (Basel) 2021;10:527. doi: 10.3390/antiox10040527.", "ArticleIdList": ["10.3390/antiox10040527", "PMC8065873", "33801741"]}, {"Citation": "Zhu B, Zhang QL, Hua JW, Cheng WL, Qin LP. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review. J. Ethnopharmacol. 2018;226:143\u2013167. doi: 10.1016/j.jep.2018.08.023.", "ArticleIdList": ["10.1016/j.jep.2018.08.023", "30130541"]}, {"Citation": "Lu PH, et al. An Apriori algorithm-based association rule analysis to identify herb combinations for treating uremic pruritus using Chinese herbal bath therapy. Evid. Based Complement. Alternat. Med. 2020;2020:8854772. doi: 10.1155/2020/8854772.", "ArticleIdList": ["10.1155/2020/8854772", "PMC7704140", "33299462"]}, {"Citation": "Qi Y, et al. Comparative pharmacokinetic study of the components in Alpinia oxyphylla Miq.-Schisandra chinensis (Turcz.) Baill. herb pair and its single herb between normal and Alzheimer's disease rats by UPLC-MS/MS. J. Pharm. Biomed. Anal. 2020;177:112874. doi: 10.1016/j.jpba.2019.112874.", "ArticleIdList": ["10.1016/j.jpba.2019.112874", "31542420"]}, {"Citation": "Wei P, et al. Pharmacokinetic comparisons of five ephedrine alkaloids following oral administration of four different Mahuang\u2013Guizhi herb-pair aqueous extracts ratios in rats. J. Ethnopharmacol. 2014;155:642\u2013648. doi: 10.1016/j.jep.2014.05.065.", "ArticleIdList": ["10.1016/j.jep.2014.05.065", "24929107"]}, {"Citation": "Wang D, et al. Prognostic significance of cyclooxygenase-2 protein in pancreatic cancer: A meta-analysis. Tumour Biol. 2014;35:10301\u201310307. doi: 10.1007/s13277-014-2260-y.", "ArticleIdList": ["10.1007/s13277-014-2260-y", "25034525"]}, {"Citation": "Ding XZ, Tong WG, Adrian TE. Cyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancer. Pancreatology. 2001;1:291\u2013299. doi: 10.1159/000055827.", "ArticleIdList": ["10.1159/000055827", "12120207"]}, {"Citation": "Natale CA, et al. Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma. Cell. Mol. Gastroenterol. Hepatol. 2020;10:868\u2013880. doi: 10.1016/j.jcmgh.2020.04.016.", "ArticleIdList": ["10.1016/j.jcmgh.2020.04.016", "PMC7578406", "32376419"]}, {"Citation": "Sarosiek K, et al. Hypothyroidism in pancreatic cancer: Role of exogenous thyroid hormone in tumor invasion-preliminary observations. J. Thyroid Res. 2016;2016:2454989. doi: 10.1155/2016/2454989.", "ArticleIdList": ["10.1155/2016/2454989", "PMC4830736", "27123358"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "9"}, {"Year": "2022", "Month": "5", "Day": "17"}, {"Year": "2022", "Month": "6", "Day": "14", "Hour": "23", "Minute": "30"}, {"Year": "2022", "Month": "6", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["35701649", "PMC9198029", "10.1038/s41598-022-14174-1", "10.1038/s41598-022-14174-1"]}}], "PubmedBookArticle": []}